Clinical Trial Update: Efficacy and Safety of Trastuzumab, Capecitabine y Oxaliplatine as Treatment Gastric Cancer Metastatic (HER2)Positive [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of trastuzumab, capecitabine, and oxaliplatin for HER2-positive metastatic gastric cancer; the study completed with eff…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Fundación para el Progreso de la Oncología en Cantabria | Conditions: Stage IV Gastric Cancer With Metastasis | Phase 2 | Status: COMPLETED